Padmesh Rajput, PhD, received his bachelor of pharmacy in India and his master of science in molecular biology in the United Kingdom. He received his doctorate from University of British Columbia, Canada, with an emphasis in neurodegenerative diseases. After completing his PhD, Rajput joined the Lyden Laboratory as a postdoc and is currently working as a Research Scientist I (Faculty) on translational and preclinical projects. He also manages collaborative projects at Cedars-Sinai, as well as other institutions. Rajput's research focus includes translational and preclinical research to establish effective therapeutic approaches for stroke therapy, determining the role of thrombin and thrombin receptors in pathophysiology of stroke, role of therapeutic hypothermia in stroke and developing new therapeutic and diagnostic approaches using microRNA and exosomes in ischemia.